BioLab Sciences Membrane Wrap™ is a unique DUAL- LAYERED dehydrated human amnion membrane (dHAM) allograft composed primarily of a connective tissue matrix. It is minimally manipulated, preserving the properties that it exhibits in its natural state. The presence of the connective tissue matrix aids in supporting and protecting the wound.


WHAT TYPE OF CONDITIONS ARE TREATABLE WITH MEMBRANE WRAP™?
Diabetic Foot Ulcers
Venous Stasis Ulcers

The natural growth factors and cytokines so abundantly present in amniotic tissue aide in faster healing, greater pain reduction, and less scarring for the patient.

COVERED BY INSURANCE, INCLUDING MEDICARE

BioLab Membrane Wrap™ has been issued Q-Code: Q4205 for the following intended use:

“The patient population for use of the products includes children and adults suffering from non-healing acute and chronic wounds (diabetic, venous, mixed, venous-arterial, pressure ulcers), complex and/or open surgical wounds and burns.”

CMS HCPCS Public Meeting, May 13, 2019

FDA REGISTERED AS AN HCT/Ps

BioLab Sciences Membrane Wrap™ has been audited by the FDA and registered as a compliant HCT/Ps solely regulated under section 361 of the Public Health Service Act (PHS Act) and 21 CFR Part 1271, including the requirements of minimal manipulation and homologous intended use.

Click Here to View FDA Registration
Reimbursement Guarantee

BioLab Sciences and EMS Bio offer support to your billing department in securing reimbursements. If for any reason the insurance denies the claim, we will go to work on your behalf.

BioLab Sciences is so confident in this process that we offer a Reimbursement Guarantee that replaces the product used, free of charge, if you are denied reimbursement.

No Ethical Concerns
  • Consenting mothers
  • Scheduled cesarian births
  • Fetus is untouched
  • Rigorous health screenings

BioLab Sciences amniotic liquid allografts have been tested for potentially infectious diseases and terminally sterilized to ensure the safety of each liquid allograft. The donated tissue has been deemed acceptable for transplant and all laboratories performing these tests are registered with the FDA and certified to perform testing on human specimens under CLIA and 42 CFR part 493, or equivalent requirements.